Cargando…

Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study

BACKGROUND: The role lobectomy plays in stage IIIA/N2 non-small cell lung cancer (NSCLC) is controversial for a long time. What’s more, no previous study concentrates on whether sublobectomy can improve survival outcome for these patients, so we performed this population-based study to investigate w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Suyu, Zhang, Zhiyuan, Gu, Yang, Lv, Xin, Shi, Xuan, Liu, Meiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696201/ https://www.ncbi.nlm.nih.gov/pubmed/34956862 http://dx.doi.org/10.3389/fonc.2021.726811

Ejemplares similares

Lobectomy vs. sublobectomy for stage I non-small-cell lung cancer: a meta-analysis
por: Lv, Fang, et al.
Publicado: (2021)

Sublobectomy versus Lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study
por: Liu, Yaxin, et al.
Publicado: (2014)

A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer
por: Mu, Ju-Wei, et al.
Publicado: (2015)

Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study
por: Yu, Yue, et al.
Publicado: (2020)

Functional Preserving Sublobectomy: A Novel Method for Sublobectomy
por: Zhang, Min, et al.
Publicado: (2021)

Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy
por: Wo, Yang, et al.
Publicado: (2019)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017)

Role of Pneumonectomy in T1–4N2M0 Non-Small Cell Lung Cancer: A Propensity Score Matching Analysis
por: Wang, Suyu, et al.
Publicado: (2022)

Comparison of postoperative cough-related quality of life and recovery between sublobectomy and lobectomy for early-stage non-small cell lung cancer patients: a longitudinal study
por: Lin, Rongjia, et al.
Publicado: (2022)

Thoracoscopic Lobectomy Versus Sublobar Resection for pStage I Geriatric Non-Small Cell Lung Cancer
por: Lin, Young-Jen, et al.
Publicado: (2022)

Functional outcome and Health-related Quality of life two years after lobectomy and sublobectomy for early stage non-small cell lung cancer: A New Center Experience
por: Ali Elshorbagy, Ashraf Ali Mohammed, et al.
Publicado: (2015)

Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer
por: Jeremić, Branislav, et al.
Publicado: (2018)

Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer
por: Xie, Xiao-Hong, et al.
Publicado: (2021)

Video-Assisted Thoracoscopic Lobectomy Versus Stereotactic Body Radiotherapy Treatment for Early-Stage Non-Small Cell Lung Cancer: A Propensity Score-Matching Analysis
por: Dong, Baiqiang, et al.
Publicado: (2020)

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer
por: Hao, Bo, et al.
Publicado: (2020)

Lobectomy versus segmentectomy for stage IA3 (T1cN0M0) non-small cell lung cancer: a meta-analysis and systematic review
por: Zhang, Wanfei, et al.
Publicado: (2023)

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases
por: Li, Xin, et al.
Publicado: (2022)

Perioperative outcomes of robotic lobectomy for early-stage non-small cell lung cancer in elderly patients
por: Gallina, Filippo Tommaso, et al.
Publicado: (2022)

The Prognostic Role of Blood Inflammatory Biomarkers and EGFR Mutation Status in Stage IIIA/N2 Non-Small Cell Lung Cancer Patients Treated With Trimodality Therapy
por: Yang, Hui, et al.
Publicado: (2021)

A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis
por: Sun, Shuang, et al.
Publicado: (2021)

Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25
por: Qi, Yi‐Fan, et al.
Publicado: (2022)

V7 ENB‐guided thoracoscopic sublobectomy for stage IA synchronous multiple primary lung cancer
por: Wang, Kun, et al.
Publicado: (2022)

Clinical analysis of the impact of sublobectomy on pulmonary function
por: Yang, Haiping, et al.
Publicado: (2017)

Thoracoscopic Lobectomy versus Open Lobectomy in Stage I Non-Small Cell Lung Cancer: A Meta-Analysis
por: Cai, Yi-xin, et al.
Publicado: (2013)

Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study
por: Dong, Daling, et al.
Publicado: (2023)

Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery
por: Song, Congkuan, et al.
Publicado: (2022)

ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy
por: Yang, Xue, et al.
Publicado: (2023)

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study
por: Dong, Daling, et al.
Publicado: (2023)

Preliminary Results of Robotic Lobectomy in Stage IIIA-N2 NSCLC after Induction Treatment: A Case Control Study
por: Casiraghi, Monica, et al.
Publicado: (2021)

Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer
por: Li, Hongbo, et al.
Publicado: (2020)

Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report
por: Fu, Meng, et al.
Publicado: (2022)

Comparison of lobectomy and sublobar resection for stage I non-small cell lung cancer: a meta-analysis based on randomized controlled trials
por: Lu, Genlin, et al.
Publicado: (2023)

Advances in multimodal treatment for stage IIIA-N2 non-small cell lung cancer
por: Montemuiño Muñiz, Sara, et al.
Publicado: (2021)

The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy
por: Yang, Hui, et al.
Publicado: (2021)

Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins
por: Yuan, Meng, et al.
Publicado: (2020)

Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
por: Yang, Yong, et al.
Publicado: (2021)

Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma
por: Singh, Neetu, et al.
Publicado: (2020)

Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review
por: Shi, Yucong, et al.
Publicado: (2021)

Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer
por: Hattori, Aritoshi, et al.
Publicado: (2023)

Wedge resection plus adequate lymph nodes resection is comparable to lobectomy for small-sized non-small cell lung cancer
por: Ding, Hongdou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32e0ugt8psnkj088sqvbcmn5gd